OM DETTA AVSNITT
In this episode of IDEA Collider, host Mike Rea sits down with Nello Mainolfi, founder and CEO of Kymera Therapeutics. Nello shares his journey from medicinal chemist to biotech founder and discusses the opportunities and lessons learned from building a company at the forefront targeted protein degradation.
Episode Timestamps;
00:00 Welcome to Idea Collider
00:18 Kymera 2026 Catalysts
02:33 De Risking with Degraders
02:54 Targeted Protein Degradation 101
06:20 KT-621 STAT6 Degrader
08:16 Rethinking Type 2 Disease Treatment
12:21 Nello’s Path to CEO
16:32 Building a Standalone Biotech
23:19 Partnering with Big Pharma
26:51 Culture and Office Energy
32:03 Capital Plan and Potential Launches
36:24 Belief and Execution Mindset
39:00 Life Outside the Lab
40:07 Where to Follow Kymera
40:35 Closing Thanks
Don't forget to Like, Share, Subscribe, Rate, and Review!
Keep up with Nello Mainolfi & Kymera
LinkedIn: https://www.linkedin.com/in/nello-mainolfi-2b55421a/ or https://www.linkedin.com/company/kymeratherapeutics/
Website: https://www.kymeratx.com/
Follow IDEA Pharma On;
Website: https://www.ideapharma.com/
LinkedIn: https://www.linkedin.com/company/idea-pharma/
Listen to more fantastic podcast episodes: https://podcast.ideapharma.com/
